iRemedy Healthcare

iRemedy Healthcare

Early Stage


Raised to Date: Raised: $6,375

Total Commitments ($USD)


Dalmore Group

Start Date


Close Date

Not Provided

Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Rolling Commitments ($USD)

Reporting Date


% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Stuart, Florida

iRemedy Healthcare is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. The company uses artificial intelligence to solve issues in the medical supply chain. iRemedy Healthcare has created a large procurement marketplace for doctors and hospitals to get lifesaving supplies easily at transparent pricing and with constant supply monitoring. The business has over 10,000 customers, 500,000 products, and generated $52 million in revenue in 2022. Tony Paquin and Gary Paquin founded iRemedy Healthcare in 2007. The current crowdfunding campaign has a maximum target of $25 million. The campaign proceeds will be used for acquisition and investment opportunities, growth strategies, working capital, and general corporate purposes.

Balance Sheet

Cash and Cash Equivalents


Investment Securities


Accounts and Notes Receivable


Property, Plant and Equipment (PP&E)


Total Assets


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: WithumSmith+Brown, PC
Financials as of: 02/12/2023
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
iRemedy Healthcare 02/12/2024 Dalmore Group - $6,375 Equity - Common Funded RegA+
iRemedy Healthcare 09/30/2023 Republic $302,000,000 $237,787 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Add to portfolio
iRemedy Healthcare on Dalmore Group 2023
Platform: Dalmore Group
Security Type: Equity - Common
Price per Share: $8.50

Follow company

Follow iRemedy Healthcare on Dalmore Group 2023

Buy iRemedy Healthcare's Deal Report

Warning: according to the close date for this deal, iRemedy Healthcare may no longer be accepting investments.

iRemedy Healthcare Deal Report

Get KingsCrowd’s comprehensive report on iRemedy Healthcare including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether iRemedy Healthcare is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the iRemedy Healthcare deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge